Stock Market News
Lifeline Scientific to merge with Shanghai Genext
International provider of clinical products and services in the field of transplantation, Lifeline Scientific, announced on Friday that it has entered into a definitive merger agreement with Shanghai Genext Medical Technology Company and its affiliates.
The AIM-traded firm described SGM as a medical products company serving the field of transplantation in the Asia region.
Pursuant to the merger agreement, SGM's affiliate would acquire all of the issued and to-be-issued shares of common stock of LSI for an aggregate consideration of up to$87.8m in cash.
The LSI board of directors unanimously approved the merger agreement, and will recommend shareholders vote in favour of the merger and acquisition.
"Subject to shareholder approval, the agreement with SGM represents an all cash offer and provides full liquidity for all LSI shareholders at closing," said Lifeline Scientific CEO David Kravitz.
"Following the merger, we believe the combined group will be one of the largest and fastest growing global medical technology companies dedicated to serving the clinical transplant sector."
Kravitz said the merger also represents an "excellent opportunity" for both SGM and LSI to broaden their products and services portfolios to better address the needs of transplant programme clients.
"Since announcing its strategic review in September 2015, the LSI board had been actively reviewing a number of options to enhance shareholder value, including possible strategic mergers, strategic acquisitions, a potential sale of the company, and a potential listing of the company's shares on the NASDAQ market," he explained.
"The acquisition of LSI by SGM represents the culmination of the company's strategic review process."
The AIM-traded firm described SGM as a medical products company serving the field of transplantation in the Asia region.
Pursuant to the merger agreement, SGM's affiliate would acquire all of the issued and to-be-issued shares of common stock of LSI for an aggregate consideration of up to$87.8m in cash.
The LSI board of directors unanimously approved the merger agreement, and will recommend shareholders vote in favour of the merger and acquisition.
"Subject to shareholder approval, the agreement with SGM represents an all cash offer and provides full liquidity for all LSI shareholders at closing," said Lifeline Scientific CEO David Kravitz.
"Following the merger, we believe the combined group will be one of the largest and fastest growing global medical technology companies dedicated to serving the clinical transplant sector."
Kravitz said the merger also represents an "excellent opportunity" for both SGM and LSI to broaden their products and services portfolios to better address the needs of transplant programme clients.
"Since announcing its strategic review in September 2015, the LSI board had been actively reviewing a number of options to enhance shareholder value, including possible strategic mergers, strategic acquisitions, a potential sale of the company, and a potential listing of the company's shares on the NASDAQ market," he explained.
"The acquisition of LSI by SGM represents the culmination of the company's strategic review process."
Related share prices |
---|
Lifeline Scientific Inc. (Reg S) (LSI) share price |
Stock News headlines are gathered from financial news sources around the web. Views and opinions on each item are from their respective authors and website. They are not opinions of LiveCharts.co.uk
Get a free widget for your website with our latest headlines.
You can now add our live prices and new headlines to your website.The news widget features quotes for Oil prices, spot Gold price and Indices plus a choice of news channel for healines.
Top Shares pages
- Share price quotes
- Share charts
- Share watch list
- Company Results Calendar
- Top Large UK Shares
- UK Market Sectors
- Stock market news
- Company news
- Share tips
- A-Z company search
More share features
POPULAR Share Prices
- Royal Mail share price
- Lloyds share price
- HSBC share price
- Barclays share price
- Prudential share price
- Santander share price
- RBS share price
- Diageo share price
- Standard Life Share Price
- BP share price
- Vodafone share price
- British Airways
- Centrica share price
- Tesco share price
- Taylor Wimpey Share Price
- National Grid
- GKP Share Price
- Marks and Spencer
- Rolls Royce
- Rio Tinto
- Morrisons Share Price
- Aviva Share Price
- ASOS Share price
- RPT Share Price
- SXX Share Price
- Easyjet Share Price
- Next Share Price
- Thomas Cook Share Price
- SSE Share Price
- IAG Share Price
- Boohoo share price
- Greene King Share Price
- Marstons share price
- NUOG share price
- UKOG share price
- SOLG share price